Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Methylprednisolone Acetate(Depo-Medrate) has the ability to inhibit oxygen free radicals and can be used to treat acute spinal cord injuries.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
25 mg | Inquiry | $ 39.00 | |
50 mg | Inquiry | $ 66.00 | |
100 mg | Inquiry | $ 95.00 | |
500 mg | Inquiry | $ 227.00 |
Description | Methylprednisolone Acetate(Depo-Medrate) has the ability to inhibit oxygen free radicals and can be used to treat acute spinal cord injuries. |
In vivo | Typical features of early avascular necrosis (AVN) of the femoral head are induced by the combination of intramuscular injection of Methylprednisolone Acetate (30 mg/kg) and additional oral doses of 13 mg/kg for 10 consecutive days with LPS[1] |
Synonyms | Depo-Medrate, Depometicort, Depo-Medrin, Depo-medrol, Depomedrone, Lemod |
Molecular Weight | 416.51 |
Formula | C24H32O6 |
CAS No. | 53-36-1 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: Soluble
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Methylprednisolone Acetate 53-36-1 Immunology/Inflammation Metabolism NF-Κb Reactive Oxygen Species Depo-Medrate Depometicort Depo-Medrin Depo-medrol Depomedrone Lemod inhibitor inhibit